Umban, Angela .

HRN: 27-46-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/11/2025
08/01/2025
IV
2.25 Grams
Q6h
Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: